ZNF304 has also been reported as a regulator of the RAS pathway by recruitment of an epigenetic silencing complex in tumor suppressor genes in colorectal cancer (Serra et al., 2014) and as a promoter of cell survival in ovarian cancer (Aslan et al., 2015). This evidence concerns the gene ZNF304 and ovarian carcinoma.